On Monday, Mainz Biomed N.V (NASDAQ: MYNZ) was 13.63% up from the session before settling in for the closing price of $6.09. A 52-week range for MYNZ has been $3.65 – $48.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 25.92% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 63.58%. With a float of $1.89 million, this company’s outstanding shares have now reached $2.00 million.
In an organization with 71 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 56.91%, operating margin of -2975.47%, and the pretax margin is -2936.5%.
Mainz Biomed N.V (MYNZ) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mainz Biomed N.V stocks. The insider ownership of Mainz Biomed N.V is 5.53%, while institutional ownership is 0.20%.
Mainz Biomed N.V (MYNZ) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.58% per share during the next fiscal year.
Mainz Biomed N.V (NASDAQ: MYNZ) Trading Performance Indicators
You can see what Mainz Biomed N.V (MYNZ) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -65.57, a number that is poised to hit -3.60 in the next quarter and is forecasted to reach -9.20 in one year’s time.
Technical Analysis of Mainz Biomed N.V (MYNZ)
Let’s dig in a bit further. During the last 5-days, its volume was 0.35 million. That was better than the volume of 0.15 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.52%. Additionally, its Average True Range was 0.98.
During the past 100 days, Mainz Biomed N.V’s (MYNZ) raw stochastic average was set at 26.39%, which indicates a significant decrease from 82.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 112.94% in the past 14 days, which was lower than the 154.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.82, while its 200-day Moving Average is $14.83. However, in the short run, Mainz Biomed N.V’s stock first resistance to watch stands at $7.78. Second resistance stands at $8.64. The third major resistance level sits at $9.78. If the price goes on to break the first support level at $5.78, it is likely to go to the next support level at $4.64. The third support level lies at $3.78 if the price breaches the second support level.
Mainz Biomed N.V (NASDAQ: MYNZ) Key Stats
There are 2,001K outstanding shares of the company, which has a market capitalization of 15.37 million. As of now, sales total 900 K while income totals -26,300 K. Its latest quarter income was 210 K while its last quarter net income were -5,180 K.
